Works matching Peter O'Donnell


Results: 799
    1
    2
    3
    4
    5
    6
    7

    In Reply.

    Published in:
    2022
    By:
    • Lacouture, Mario E;
    • Patel, Anisha B;
    • Rosenberg, Jonathan E;
    • O'Donnell, Peter H
    Publication type:
    Letter to the Editor
    8

    In Reply.

    Published in:
    2022
    By:
    • Lacouture, Mario E;
    • Patel, Anisha B;
    • Rosenberg, Jonathan E;
    • O'Donnell, Peter H
    Publication type:
    Letter to the Editor
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.

    Published in:
    Leukemia & Lymphoma, 2010, v. 51, n. 12, p. 2240, doi. 10.3109/10428194.2010.520773
    By:
    • O'Donnell, Peter H.;
    • Artz, Andrew S.;
    • Undevia, Samir D.;
    • Pai, Rish K.;
    • Del Cerro, Paula;
    • Horowitz, Sarah;
    • Godley, Lucy A.;
    • Hart, John;
    • Innocenti, Federico;
    • Larson, Richard A.;
    • Odenike, Olatoyosi M.;
    • Stock, Wendy;
    • Van Besien, Koen
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Good News from The Front.

    Published in:
    Applied Clinical Trials, 2007, v. 16, n. 6, p. 36
    By:
    • O'Donnell, Peter
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Battle of Biosimilars.

    Published in:
    Applied Clinical Trials, 2006, v. 15, n. 2, p. 38
    By:
    • O'Donnell, Peter
    Publication type:
    Article